Czechia· CZ-0208770
TŘEZALKA APOMEDICA
A hyperici herba product containing st. john´s wort dry extract, quantified, registered in Czechia by Apomedica Pharmazeutische Produkte GmbH, Graz. The same ATC class is registered in 7 of our 19 countries.
Checked against SÚKL (Czech Republic) on
Informational only — not a medical device.
Where it is registered
Hyperici herba is registered in 7 of 19 countries.
Countries holding a registration under ATC N06AX25 (hyperici herba), each read from that country’s own register.
- This record: Czechia, from SÚKL (Czech Republic)
- 4 of them publish a price we can compare per daily dose
Hyperici herba · ATC N06AX25
7 / 19 countries
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Netherlands
- Polandprice
- Switzerlandprice
The record
At a glance
SÚKL (Czech Republic)- Active substance
- ST. JOHN´S WORT DRY EXTRACT, QUANTIFIED
- Manufacturer
- Apomedica Pharmazeutische Produkte GmbH, Graz
- Country
- Czechia (CZ)
- ATC code
- N06AX25
- ATC class
- Hyperici herba
- Reimbursed
- Not published by this register
- Source register
- SÚKL (Czech Republic)
- Last checked
- September 28, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
293 interactions on record for hyperici herba.
Graded by severity as the source publishes them — 141 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Hyperici herba · interactions on record
293 records
- 141 severe
- 144 moderate
- 8 minor
Most severe, free to view
- OndansetronA04AA01severe
- GranisetronA04AA02severe
- DolasetronA04AA04severe
- PalonosetronA04AA05severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under N06AX25
Hyperici herba, as other registers publish it.
- NetherlandsA.Vogel Hyperiforce, tablettenA.Vogel B.V.
- SwitzerlandDeprivita
- SwitzerlandDeprivita
- SwitzerlandDeprivita, FilmtablettenPermamed AG
- SwitzerlandEssenssia 250 mg, comprimés pelliculésLabatec Pharma SA
- SwitzerlandEssenssia 500 mg, comprimés pelliculésLabatec Pharma SA
- FinlandHyperiforce NovaA. Vogel Oy
- SwitzerlandHyperiforce, TablettenA.Vogel AG
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c1a09c0c-559e-4ff8-8ad6-3096e7b4da20 GET /v1/drugs/c1a09c0c-559e-4ff8-8ad6-3096e7b4da20?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "CPS DUR",
"source": "sukl",
"strength": null,
"pack_size": "60",
"substance": "ST. JOHN´S WORT DRY EXTRACT, QUANTIFIED",
"cz_kod_sukl": "0208770",
"product_type": "HE",
"substance_codes": "3884",
"registration_state": "R",
"registration_number": "94/245/15-C"
}See everything about hyperici herba.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.